Atrasentan is a selective, orally active endothelin A (ETA) receptor antagonist. It can be used in studies related to glomerular disease and diabetic nephropathy.
Molecular Weight:
542.69
Purity:
>99.0%
CAS Number:
[173937-91-2]
Formula:
C29H38N2O6S
Target:
Endothelin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted